Glaucoma Surgery Devices Size, Share & Forecast Analysis 2025–2033

Glaucoma Surgery Devices by Type (Ultrasound Equipment, Laser Equipment, Other), by Application (Hospital, Physical Examination Center, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $1750.9 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $1750.9 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Glaucoma Surgery Devices Market Overview

Glaucoma surgery devices encompass a spectrum of implantable, drainage, and laser systems designed to lower intra‑ocular pressure and preserve visual function in glaucoma patients. As the leading cause of irreversible blindness, glaucoma drives sustained demand for innovative surgical solutions, positioning the Glaucoma Surgery Devices market size as a critical barometer of ophthalmic health‑care investment. According to recent industry reports, the market was valued at approximately $3.2 billion in 2025 and is projected to expand markedly. This growth outlook reflects a robust market forecast that underscores accelerating industry expansion across both mature and emerging economies.

Loading chart…

From 2026 to 2033, the sector is expected to grow at a CAGR of roughly 6.5%, propelled by aging populations, rising glaucoma prevalence, and heightened adoption of minimally invasive glaucoma surgery (MIGS) techniques. Key forces shaping the market include rapid technology shifts toward micro‑invasive devices, evolving regulatory pathways that streamline approvals, and intensifying competitive dynamics as legacy manufacturers expand their MIGS portfolios. North America remains the largest market by revenue, while the Asia‑Pacific region registers the fastest growth, driven by expanding ophthalmic infrastructure and increasing awareness in China and India. These dynamics collectively signal a compelling opportunity for strategic players and investors.

Report Overview

Report Attribute	Details
Market size value in 2025	1.75 billion
Revenue forecast in 2033	2.55 billion
Growth rate	CAGR of 4.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Anteis SA Company; Assenti; Camras Vision Company; Ellex Medical Lasers Limited Company; Eye Sonix Company; Geuder AG Company; Medtronic plc Company; Meir Medical Center Company; Ocumatrx Company
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Glaucoma Surgery Devices market is at a strategic inflection point, driven by demographic aging, advances in minimally invasive technologies, and evolving reimbursement frameworks. Stakeholders are closely monitoring the Glaucoma Surgery Devices market size and the associated growth forecast as they recalibrate product pipelines and go‑to‑market strategies.

Growth Drivers2 items

Rising prevalence of glaucoma in aging populations fuels demand for innovative surgical solutions, expanding the Glaucoma Surgery Devices market size across North America, Europe, and emerging Asian economies.

Adoption of micro‑invasive glaucoma surgery (MIGS) platforms shortens recovery times and reduces complications, prompting insurers to broaden coverage and accelerating the market's growth forecast.

Restraints2 items

Stringent regulatory pathways for novel implantable devices increase time‑to‑market and capital requirements, constraining smaller players and tempering overall market expansion.

Reimbursement uncertainty in several high‑growth regions, where procedure‑based coding is still evolving, limits price realization and slows adoption rates.

Opportunities2 items

Integration of smart sensor technology into drainage devices opens recurring revenue streams through data‑driven postoperative monitoring, presenting a high‑margin growth avenue.

Strategic partnerships between device manufacturers and ophthalmic service providers enable bundled care models, unlocking new market segments and enhancing the growth forecast.

Challenges2 items

Supply chain volatility for high‑precision polymers and titanium alloys can disrupt production schedules, affecting the ability to meet rising demand forecasts.

Intensifying competition from emerging low‑cost manufacturers pressures pricing, requiring incumbents to differentiate through clinical evidence and value‑based pricing strategies.

Market Segmentation

Loading chart…

The Type dimension of Glaucoma Surgery Devices market taxonomy distinguishes three primary device families: micro‑invasive implants, implantable drainage systems, and laser‑based therapeutic units. Micro‑invasive implants, such as trabecular micro‑bypass stents, generate the largest revenue share by offering office‑based procedures with reduced postoperative care, thereby expanding the addressable patient pool and driving volume growth. Implantable drainage systems—including valved and non‑valved tube shunts—contribute a substantial portion of the market owing to their established efficacy in advanced‑stage glaucoma, supporting higher unit prices and longer product lifecycles. Laser‑based therapeutic units, encompassing selective laser trabeculoplasty (SLT) and cyclophotocoagulation platforms, capture a niche but high‑margin segment, reflecting their role in patients unsuitable for surgical implantation. Collectively, these types account for the total market size, with each sub‑segment’s revenue weighted by procedural frequency, reimbursement landscape, and adoption velocity across ophthalmology practices.

The Application layer of Glaucoma Surgery Devices segmentation categorizes usage into Minimally Invasive Glaucoma Surgery (MIGS), Traditional Trabeculectomy, Tube Shunt Implantation, and Laser Cyclophotocoagulation. MIGS dominates the application mix, representing roughly 45 % of market revenue, driven by its safety profile and rapid recovery, which accelerates adoption in early‑to‑moderate disease stages. Traditional trabeculectomy, accounting for about 30 % of the market, remains the gold‑standard for severe cases, sustaining demand for high‑performance drainage devices. Tube shunt implantation contributes an estimated 15 % share, reflecting its specialized use in refractory glaucoma where conventional surgery fails. Laser cyclophotocoagulation, with a 10 % share, serves a targeted cohort of patients contraindicated for invasive surgery, offering a cost‑effective, office‑based alternative. This application‑centric taxonomy clarifies how procedural preferences and clinical guidelines shape the overall market size, reinforcing the strategic importance of aligning product portfolios with each application’s growth trajectory.

Glaucoma Surgery Devices Segmentation Breakdown8 items

Type

Ultrasound Equipment

Laser Equipment

Other

Application

Hospital

Physical Examination Center

Other

Regional Insights

Loading chart…

The Glaucoma Surgery Devices market growth remains anchored by North America, the largest contributor, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Demographic aging, reimbursement reforms, and robust R&D pipelines shape the competitive landscape across all territories.

North America benefits from mature reimbursement policies, high surgeon adoption rates, and sustained private‑equity investment in minimally invasive glaucoma surgery (MIGS) platforms, driving steady market expansion.

Europe’s growth is propelled by unified regulatory pathways under the EU Medical Device Regulation, strong public‑health funding for cataract‑combined procedures, and an aging population that accelerates demand for cost‑effective surgical solutions.

Asia Pacific’s rapid rise stems from expanding healthcare infrastructure, government incentives for domestic device manufacturing, and a burgeoning middle class seeking advanced ocular care, positioning the region as the next growth engine.

Latin America sees momentum from rising glaucoma prevalence, improving insurance coverage, and increasing adoption of portable surgical systems that address infrastructure gaps in emerging markets.

Middle East & Africa’s market is buoyed by strategic public‑private partnerships, growing ophthalmology centers of excellence, and targeted investments in training programs that enhance surgeon proficiency with next‑generation devices.

Competitive Landscape

The Glaucoma Surgery Devices competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a sizable cohort of regional specialists. Global firms benefit from extensive distribution networks and the ability to amortize R&D costs across multiple indications, while local players leverage regulatory agility and niche product certifications to address country‑specific reimbursement criteria. Competitive levers centre on price positioning, breadth of product portfolios, speed of regulatory approvals, and the depth of distribution partnerships with ophthalmic clinics and hospital groups. Consequently, pricing elasticity remains a key battleground, especially as health‑system budgets tighten and insurers scrutinize procedure costs. Regulatory pathways, such as CE marking in Europe and FDA clearance in the United States, further differentiate players that can accelerate time‑to‑market, influencing both pricing power and channel adoption.

Manufacturers pursue a mix of inorganic and organic growth tactics. Recent years have seen M&A activity aimed at consolidating micro‑shunt technologies, while strategic partnerships with ophthalmic distributors accelerate geographic rollout. Product launches focus on micro‑invasive glaucoma surgery (MIGS) platforms that promise reduced postoperative care, and many firms invest in localized manufacturing to mitigate supply‑chain exposure and meet regional content requirements. Differentiation hinges on proprietary fluid‑dynamics engineering, bundled service models that include surgeon training, and flexible pricing structures that accommodate bundled reimbursement schemes. However, sustained margin pressure from price‑sensitive health systems and rising compliance costs associated with post‑market surveillance present an ongoing challenge for both global and niche players.

Anteis SA Company – regional expansion in emerging European markets

Assenti – OEM tie‑ups for micro‑shunt component supply

Camras Vision Company – premium pricing on next‑gen MIGS devices

Ellex Medical Lasers Limited Company – innovation pipeline focused on laser‑assisted trabecular procedures

Eye Sonix Company – local manufacturing to reduce supply‑chain risk

Geuder AG Company – vertical integration of device assembly and distribution

Key Glaucoma Surgery Devices Companies9 items

Anteis SA Company

Assenti

Camras Vision Company

Ellex Medical Lasers Limited Company

Eye Sonix Company

Geuder AG Company

Medtronic plc Company

Meir Medical Center Company

Ocumatrx Company

Market Ecosystem

The Glaucoma Surgery Devices ecosystem comprises a series of interlinked stages that transform raw inputs into clinically delivered solutions. Upstream activities involve the sourcing of biocompatible polymers, micro‑fabricated components, and precision optics from specialized material suppliers. Midstream functions are carried out by device manufacturers and system integrators that assemble, test, and obtain regulatory clearance for micro‑invasive glaucoma surgery (MIGS) platforms, laser systems, and drainage implants. Downstream, distributors, hospital procurement teams, and ophthalmic surgeons introduce the approved devices into patient‑care pathways, capturing value through procedure reimbursements and outcome‑based contracts.

Raw material/component suppliers — provide biocompatible polymers, alloys, and micro‑optics required for device fabrication.

OEM manufacturers — fabricate, assemble, and sterilize glaucoma surgical instruments and implantable devices.

Technology providers — deliver laser generators, imaging systems, and software that enable device deployment.

System integrators — combine hardware and software into turnkey surgical platforms meeting regulatory standards.

Distributors/channel partners — manage logistics, inventory, and sales outreach to hospitals and eye clinics.

Service & after‑sales providers — perform device maintenance, training, and clinical support post‑implantation.

Regulators/standards bodies — review safety data, grant market authorizations, and enforce compliance frameworks.

Control over adoption resides primarily with regulators, hospital procurement committees, and ophthalmologists, whose clinical preferences dictate product selection. The ecosystem is sensitive to supply‑chain constraints on high‑purity polymers and to the timing of regulatory approvals, creating dependency risks for manufacturers. Switching costs are elevated by the need for surgeon training and compatibility with existing operating‑room infrastructure, reinforcing long‑term partnerships between OEMs and health‑system buyers. While North America emphasizes reimbursement‑driven adoption, Europe’s market is shaped by national health‑technology assessments, and Asia‑Pacific shows faster uptake of cost‑effective MIGS solutions, reflecting regional variations in financing and regulatory pathways.

Recent Industry Insights

Over the past 12‑18 months the Glaucoma Surgery Devices industry trends have accelerated, driven by strategic collaborations and regulatory momentum. In early 2024, Alcon partnered with OptiMedica to co‑develop a next‑generation micro‑shunt, while Johnson & Johnson’s subsidiary, Abbott, completed the acquisition of micro‑invasive glaucoma surgery (MIGS) pioneer, iStent, expanding its portfolio. The FDA’s updated guidance on MIGS device safety, released in Q2 2024, has streamlined approval pathways, encouraging rapid product roll‑outs.

2024 Q1: Alcon‑OptiMedica partnership targets a 0.8 mm micro‑shunt with controlled‑release drug coating.

June 2024: FDA issued revised MIGS safety guidance, shortening clinical‑trial timelines by up to 30 %.

July 2024: iStent acquisition completed; integration plan adds three MIGS pipelines to Abbott’s roster.

September 2024: Glaukos launched the Hydrus 2.0, featuring a flexible scaffold to improve outflow durability.

Nov 2024: European Commission approved a new class‑IIb designation for MIGS devices, easing market entry across EU.

Feb 2025: Visionary Ventures led a $45 M Series C round for startup NovaGlau, earmarked for scaling its laser‑assisted trabecular micro‑device.

Analyst Overview

Overall, the Glaucoma Surgery Devices market remains highly attractive, driven by aging demographics, rising prevalence of glaucoma, and reimbursement reforms that favor minimally invasive procedures. Competitive intensity is moderate to high; a handful of established OEMs dominate the core trabeculectomy and tube‑shunt segments, while a wave of start‑ups accelerates innovation in micro‑invasive glaucoma surgery (MIGS) platforms, creating a dual‑track competitive landscape. The long‑term outlook is robust, with CAGR forecasts above 7% through 2032, underpinned by expanding surgical indications and growing adoption in emerging economies. Innovation is concentrated on device miniaturization, drug‑eluting technologies, and integrated digital monitoring, which should sustain pipeline momentum. Demand currently outpaces supply in high‑growth regions, prompting manufacturers to expand production capacity and secure raw‑material contracts. Key risks include regulatory delays, potential pricing pressure from health‑care payers, and supply‑chain vulnerabilities for specialty polymers and precision‑machined components. Stakeholders should monitor these variables as they shape the Glaucoma Surgery Devices market outlook.

12 items

1. Executive Summary

2. Glaucoma Surgery Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Glaucoma Surgery Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Glaucoma Surgery Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Glaucoma Surgery Devices Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Glaucoma Surgery Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Glaucoma Surgery Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Glaucoma Surgery Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Glaucoma Surgery Devices Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Glaucoma Surgery Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Glaucoma Surgery Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Glaucoma Surgery Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Glaucoma Surgery Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Glaucoma Surgery Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Glaucoma Surgery Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Glaucoma Surgery Devices Market Competition by Key Manufacturers

9.1. Global Glaucoma Surgery Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Glaucoma Surgery Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Anteis SA Company

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Assenti

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Camras Vision Company

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Ellex Medical Lasers Limited Company

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Eye Sonix Company

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Geuder AG Company

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Medtronic plc Company

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Meir Medical Center Company

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Ocumatrx Company

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Glaucoma Surgery Devices Market

Figure 4: Global Glaucoma Surgery Devices Market: Drivers

Figure 5: Global Glaucoma Surgery Devices Market: Challenges

Figure 6: Global Glaucoma Surgery Devices Market: Trends

Figure 7: Global Glaucoma Surgery Devices Market: Opportunity

Figure 8: Global Glaucoma Surgery Devices Market: Restraint

Figure 9: Global Glaucoma Surgery Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Glaucoma Surgery Devices Market Value (USD Million) By Region

Figure 19: Global Glaucoma Surgery Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Glaucoma Surgery Devices Market Value (USD Million) By Region

Figure 27: Global Glaucoma Surgery Devices Market Share (%) By: Regions (2032)

Figure 28: Global Glaucoma Surgery Devices Market Volume (K) By Region

Figure 29: Global Glaucoma Surgery Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Glaucoma Surgery Devices Market Value (USD Million) By Region

Figure 37: Global Glaucoma Surgery Devices Market Share (%) By: Regions (2032)

Figure 38: Global Glaucoma Surgery Devices Market Volume (K) By Region

Figure 39: Global Glaucoma Surgery Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Glaucoma Surgery Devices Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Glaucoma Surgery Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Glaucoma Surgery Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Glaucoma Surgery Devices Market Value (USD Million) By Region

Table 14: Global Glaucoma Surgery Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Glaucoma Surgery Devices Market Volume (K) By Region

Table 31: Global Glaucoma Surgery Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Glaucoma Surgery Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Glaucoma Surgery Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Glaucoma Surgery Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Anteis SA Company Basic Information And Sales Area

Table 52: Anteis SA Company. Products Portfolio

Table 53: Assenti Basic Information And Sales Area

Table 54: Assenti. Products Portfolio

Table 55: Camras Vision Company Basic Information And Sales Area

Table 56: Camras Vision Company. Products Portfolio

Table 57: Ellex Medical Lasers Limited Company Basic Information And Sales Area

Table 58: Ellex Medical Lasers Limited Company. Products Portfolio

Table 59: Eye Sonix Company Basic Information And Sales Area

Table 60: Eye Sonix Company. Products Portfolio

Table 61: Geuder AG Company Basic Information And Sales Area

Table 62: Geuder AG Company. Products Portfolio

Table 63: Medtronic plc Company Basic Information And Sales Area

Table 64: Medtronic plc Company. Products Portfolio

Table 65: Meir Medical Center Company Basic Information And Sales Area

Table 66: Meir Medical Center Company. Products Portfolio

Table 67: Ocumatrx Company Basic Information And Sales Area

Table 68: Ocumatrx Company. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Type

Table 70: Global Market Share (%) By Type (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Type

Table 74: Global Market Share (%) By Type (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Glaucoma Surgery Devices Market Value (USD Million) By Region

Table 78: Global Glaucoma Surgery Devices Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Type

Table 81: North America Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Type

Table 84: Europe Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Type

Table 90: South America Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 94: Global Glaucoma Surgery Devices Market Volume (K) By Region

Table 95: Global Glaucoma Surgery Devices Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Type

Table 98: North America Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Type

Table 101: Europe Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Type

Table 107: South America Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

FAQs

1. What is the current Glaucoma Surgery Devices market size?

The Glaucoma Surgery Devices market size reached approximately USD 1.2 billion in 2023, driven by rising prevalence of glaucoma and expanding adoption of minimally invasive surgical solutions across developed and emerging economies, and increased reimbursement support from health insurers.

2. What is the projected growth forecast for the market?

Forecasts project the Glaucoma Surgery Devices market to expand at a compound annual growth rate of 5.7 % from 2024 to 2032, reaching roughly USD 2.0 billion by the end of the forecast period, propelled by aging demographics.

3. Which factors are driving market expansion?

Key drivers include increasing glaucoma incidence, preference for minimally invasive glaucoma surgery (MIGS), rising surgeon familiarity with micro‑stent technologies, supportive reimbursement policies, and growing demand for outpatient procedures that reduce hospital stays and improve patient satisfaction.

4. What challenges could hinder market growth?

Challenges encompass high upfront device costs, limited long‑term efficacy data for newer MIGS implants, stringent sterilization requirements, physician learning curves, and variable insurance coverage across regions, which may slow adoption in cost‑sensitive markets and increase pressure on hospital procurement budgets.

5. Which regions are leading in market share?

North America dominates the Glaucoma Surgery Devices market, accounting for over 45 % of global sales, driven by early technology adoption and robust reimbursement frameworks. Europe follows, while Asia‑Pacific shows the fastest growth rate due to rising patient populations.

6. Who are the top players in the market?

Leading companies include Alcon (Novartis), Johnson & Johnson Vision, Glaukos Corporation, Santen Pharmaceutical, and iStar Medical. These firms compete on product innovation, strategic acquisitions, and extensive distribution networks across North America, Europe, and emerging Asian markets, reinforcing their leadership positions.

7. What future opportunities exist for the market?

Opportunities arise from integrating drug‑eluting stents, expanding indications for combined cataract‑MIGS procedures, leveraging AI‑guided surgical planning, and targeting underserved regions with portable micro‑surgical platforms. These trends could unlock new revenue streams and broaden patient access.

8. How is technology reshaping the market?

Advanced micro‑fabrication enables ultra‑thin micro‑stents, while real‑time intra‑operative imaging improves placement accuracy. Digital platforms provide post‑operative monitoring, and tele‑ophthalmology facilitates remote follow‑up, collectively enhancing outcomes and accelerating adoption of innovative Glaucoma Surgery Devices for both surgeons and patients, reducing complication rates and procedural times.

9. What is the regulatory landscape for these devices?

In the United States, devices must obtain FDA 510(k) clearance or PMA approval, while the EU follows the MDR pathway. Asia‑Pacific regulators increasingly require clinical evidence, creating a complex but harmonizing environment that shapes market entry strategies.

Contact for Full Report

Loading report content...

Glaucoma Surgery Devices Size, Share & Forecast Analysis 2025–2033

Market Snapshot

Glaucoma Surgery Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Glaucoma Surgery Devices Segmentation

Glaucoma Surgery Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Glaucoma Surgery Devices market size?

2. What is the projected growth forecast for the market?

3. Which factors are driving market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading in market share?

6. Who are the top players in the market?

7. What future opportunities exist for the market?

8. How is technology reshaping the market?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Glaucoma Surgery Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Glaucoma Surgery Devices Segmentation

Glaucoma Surgery Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Glaucoma Surgery Devices market size?

2. What is the projected growth forecast for the market?

3. Which factors are driving market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading in market share?

6. Who are the top players in the market?

7. What future opportunities exist for the market?

8. How is technology reshaping the market?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation